Medical Enzyme Technology Market: Advancements in Enzyme Engineering to Emerge as Key Trend in Medical Enzyme Technology Market
According to our new research study on “Medical Enzyme Technology Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Enzyme Type and Application,” the market is expected to reach US$ 6,700.00 million by 2028 from US$ 4,012.57 million in 2020; it is estimated to grow at a CAGR of 6.7% from 2021 to 2028.
Enzymes play a crucial role in the metabolic activities of all organisms, whether animal, human, plant, or microbial. They have an extensive range of applications in microbial biotechnology and diagnosis processes. The abnormality of the enzyme metabolism system leads to many metabolic diseases. Studies have shown that many diseases are related to the components of the enzyme metabolism system and have been widely used in the clinical examination as a specific disease marker. Further, enzymes can be used as medicines to treat a range of diseases; they are called medicinal enzymes. For example, trypsin can be used not only to accelerate wound healing and dissolve blood clots but also to remove necrotic tissue and inhibit the proliferation of contaminating microorganisms. L-asparaginase can be used to treat cancer by depriving nutrients needed by the growth of cancer cells. Protease (like multi-enzyme tablets) can be used to treat dyspepsia, and it has an anti-inflammatory effect. Moreover, lipase, superoxide dismutase, nattokinase, soybean meal plasmin, and thrombin, among others, can be used to treat diseases.
Request for sample Pages on Medical Enzyme Technology Market at: https://www.theinsightpartners.com/sample/TIPRE00020828/
Medical Enzyme Technology Market Competitive analysis and Landscape
The medical enzyme technology market majorly consists of companies such as Merck; Thermo Fisher Scientific Inc.; Novozymes; TAKEDA PHARMACEUTICAL COMPANY LIMITED; Agilent Technologies; Inc.; Danaher (Cytiva); Sanofi; Asahi Kasei Corporation; Promega Corporation; Amano Enzyme Inc; and Genzyme Corporation. The companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio. For instance, in March 2021, Amano Enzyme Inc. introduced Umamizyme Pulse, a non-GMO enzyme engineered for use in a variety of plant protein products to produce a good, savory (umami) flavor similar to that produced by monosodium glutamate (MSG); the products also provide the feel of richness and complexity (kokumi).
The medical enzyme technology market has been analyzed on the basis of enzyme type, application, and region. The market based on region is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report emphasizes on parameters such as market trends, technological advancements, market dynamics, and leading company’s competitive landscape analysis to offers insights and in-depth analysis of the medical enzyme technology market. It also includes the analysis of COVID-19 pandemic across the market in all the key regions.
Advancements in Enzyme Engineering to Emerge as Key Trend in Medical Enzyme Technology Market
Enzyme engineering plays a fundamental role in the development of efficient biocatalysts for biotechnology, life sciences, and biomedicine. Enzyme engineering is the process of tailoring new biocatalysts with improved properties by altering their amino acid sequences. Despite the immensity of possible alterations, this procedure has already yielded remarkable results in the form of unique designs and optimization of enzymes for chemical and pharmaceutical biosynthesis, regenerative medicine, food production, waste biodegradation, and biosensing.
Apart from classical rational design and directed evolution approaches, machine learning (ML) methods are being increasingly applied to find patterns in data that help predict protein structures; improve enzyme stability, solubility, and function; predict substrate specificity; and guide rational protein design. Machine learning is a third approach to designing new biocatalysts, which has been gaining attention since the past few decades. Unlike the model-driven rational designing methods, this strategy is data driven as it identifies patterns in the existing data to predict properties of an unknown but similar input. In January 2020, Curative Enzymes, a product and service provider, launched the enzyme engineering and modification service to help major clients.
With the emergence of new techniques and methods to reconstruct and engineer enzymes, working in protein engineering has become more convenient, putting light on new semisynthetic or synthetic biocatalysts and molecules for industrial applications. Thus, advancements in enzyme engineering are likely to be a prevalent trend in the market during the forecast period.
Segmentation Review
The medical enzyme technology market, by enzyme type, is segmented into digestive enzymes, thrombolytic enzymes, hydrolases, and endonucleases. The hydrolases segment held the largest share of the market in 2020; further, the thrombolytic enzymes segment is anticipated to register the highest CAGR of 7.2% in the market during the forecast period.
The medical enzyme technology market, by application, is segmented into disease treatment, diagnostic tools, biomedical research, and others. The disease treatment segment held the largest share of the market in 2020, and the same segment is anticipated to register the highest CAGR of 7.1% in the market during the forecast period.
Buy Complete Report of medical enzyme technology market study at: https://www.theinsightpartners.com/buy/TIPRE00020828/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876